期刊文献+

2007年低钠血症治疗指南(续) 被引量:5

Treatment guidelines for hyponatremia in 2007
原文传递
导出
摘要 2.3高容量性低钠血症所有与水肿形成有关的疾病治疗,都需要食物限钠和利尿治疗。发生低钠血症时,为达到溶质一自由水的负平衡以及限制液体的摄入,必须使其低于不感性体液丢失和尿液之和,但这很难达到。低钠血症是否只是慢性心衰(CHF)或是肝硬化严重的标志,或是治疗无效的表现,目前还不清楚。但是因为低钠血症可引起认知功能障碍,限制了其他有效治疗的应用。
作者 王燕 顾锋
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2010年第10期897-900,共4页 Chinese Journal of Practical Internal Medicine
  • 相关文献

参考文献9

  • 1Licata G, Di Paspuale P, Parrinello G, et al. Effects of high-dose furosemide and small-volume hypertonic saline solution in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects [ J ]. Am Heart J, 2003, 145:459 -466.
  • 2Choudhury J, Sanyal AJ. Treatment of ascites [ J ]. Curr treat Options Gastronenterol,2003 ,6 :481 -491.
  • 3Thibonnier M,Conarty DM, Preston JA,et al. Molecular pharmacology of human vasopressin receptors [ J ]. Adv Exp Mad Biol, 1998,449:251 - 276.
  • 4Ohnishi A, Orita Y, Okahara R, et al. Potent aquaretic agent:a novel nonpeptide selective vasopressin 2 antagonist (OPC- 31260 ) in men [ J ]. J Clin Invest, 1993,92:2653 - 2659.
  • 5Greenberg A, Verbalis JG. Vasopressin receptor antagonists [ J ]. Kidney Int,2006,69:2124 - 2130.
  • 6Schrier RW, Gross P, Gheorghiade M,et al. Tolvaptan, a selective oral vasopressin V 2-receptor antagonist, for hyponatremia [ J ]. N Engl J Med ,2006,355:2099 - 2112.
  • 7Adrogue H J, Madias NE. Hyponatremia [ J ]. N Engl J Med,2000, 342 : 1581 - 1589.
  • 8Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of tolvaptan,in patients hospita|ized for worsening heart failure: the EVEREST Outcome Trial[ J ]. JAMA,2009,297 : 1319 - 1331.
  • 9Renneboog B, Musch W, Vandemergel X, et al. Mild chronic hyponatremia is associated with falls unsteadiness, and attention deficits [ J ]. Am J Med,2006,119:71. e1- e8.

同被引文献28

  • 1陈灏珠.心脏病学[M].7版.北京:人民卫生出版社,2007:1539.
  • 2Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotie syndrome, cirrhosis, and pregnancy (1) [J]. N Engl J Med, 1988,319(16) :1065-1072.
  • 3Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2) [J]. N Engl J Med, 1988,319(17) :1127-1134.
  • 4Braunwald E, Plauth WH, Morrow AG. A method for detection and quantification of impaired sodium excretion. Results of an oral sodium tolerance test in normal subjects and in patients with heart disease[J]. Circulation, 1965,32 (8) : 223-231.
  • 5Takasu T, Lasker N, Shalhoub RJ. Mechanisms of hyponatremia in chronic congestive heart failure [J]. Ann Intern Med,1961,55(9) :368-383.
  • 6MacFadyen RJ, Lee AF, Morton JJ, et al. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure? [J]. Heart, 1999,82(1) :57-61.
  • 7Weber KT, Villarreal D. Aldosterone and antialdosterone therapy in congestive heart failure[J]. Am J Cardiol, 1993,71 (3) :3A-11A.
  • 8Cohn JN. Overview of the treatment of heart failure[J]. Am J Cardiol, 1997,80(11A) : 2L-6L.
  • 9王吉耀.内科学[M].北京:人民卫生出版社,2004.245.
  • 10陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部